Product Description
Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most common type is open-angle glaucoma with less common types including closed-angle glaucoma and normal-tension glaucoma. Open-angle glaucoma develops slowly over time and there is no pain. Peripheral vision may begin to decrease followed by central vision resulting in blindness if not treated. Closed-angle glaucoma can present gradually or suddenly. The sudden presentation may involve severe eye pain, blurred vision, mid-dilated pupil, redness of the eye, and nausea.Vision loss from glaucoma, once it has occurred, is permanent.
The Glaucoma market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Glaucoma market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Glaucoma Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Glaucoma market are:
Carl Zeiss Meditec
Santen
Abbott
Iridex Corporation
Pfizer Inc.
Canon
Ellex Medical Lasers
Merck & Co., Inc.
Topcon Medical Systems
Lumenis
Accutome
Alcon
OPHTEC
Essilor
Novartis AG
Teva Pharmaceuticals
Allergan Plc
Nidek
AqueSys
Akorn, Inc.
Optos
Bausch & Lomb
Most important types of Glaucoma products covered in this report are:
Drugs
Laser
Invasive Surgery
Most widely used downstream fields of Glaucoma market covered in this report are:
Hospital
Ambulatory Surgery Centers
Others
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.
